Data / Form D filings / Serina Therapeutics, Inc.
Serina Therapeutics, Inc.: Form D filings
Serina Therapeutics, Inc., a biotechnology company in Huntsville, AL, filed 16 Form D notices with the SEC between 2012 and 2023. The latest, on March 30, 2023, reports $10 million sold of a $10 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 601 GENOME WAY, SUITE 2001, Huntsville, AL, 35806
- Phone
- (256) 327-0566
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Alabama
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1558525
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 30, 2023 | New notice | $10,000,000 | $10,000,000 | 1 | Mar 15, 2023 | sec.gov | |
| Nov 14, 2022 | New notice | $3,650,000 | $3,650,000 | 1 | Nov 10, 2022 | sec.gov | |
| Jul 15, 2022 | New notice | $5,000,000 | $1,000,000 | $4,000,000 | 3 | Jun 21, 2022 | sec.gov |
| Jun 2, 2021 | Amendment | $76,230,000 | $3,681,009 | $72,548,991 | 12 | Jul 1, 2019 | sec.gov |
| Jun 10, 2020 | Amendment | $76,230,000 | $3,681,009 | $72,548,991 | 12 | Jul 1, 2019 | sec.gov |
| Mar 4, 2020 | Amendment | $76,230,000 | $3,551,009 | $72,678,991 | 11 | Jul 1, 2019 | sec.gov |
| Jul 2, 2019 | New notice | $16,500,000 | $100,000 | $16,400,000 | 1 | Jul 1, 2019 | sec.gov |
| Apr 13, 2018 | Amendment | $32,500,000 | $8,220,966 | $24,279,034 | 18 | Jan 23, 2017 | sec.gov |
| Jan 22, 2018 | Amendment | $13,000,000 | $7,999,966 | $5,000,034 | 16 | Jan 23, 2017 | sec.gov |
| May 24, 2017 | Amendment | $13,000,000 | $6,936,501 | $6,063,499 | 13 | Jan 23, 2017 | sec.gov |
| Feb 2, 2017 | New notice | $7,800,000 | $4,055,900 | $3,744,100 | 4 | Jan 23, 2017 | sec.gov |
| Mar 18, 2015 | Amendment | $6,250,000 | $4,855,000 | $1,395,000 | 21 | Apr 11, 2014 | sec.gov |
| Mar 20, 2014 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Oct 1, 2012 | New notice | $11,150,080 | $11,150,080 | 36 | Nov 4, 2010 | sec.gov | |
| Sep 21, 2012 | New notice | $2,000,000 | $2,000,000 | 5 | Mar 1, 2008 | sec.gov | |
| Sep 19, 2012 | New notice | $2,000,000 | $2,000,000 | 4 | Nov 27, 2006 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Barbara M Fisk | Director | |
| James R Hudson, Jr. | Director | |
| Randall W Moreadith | Executive Officer, Director | |
| Steve H Ledger | Director | |
| Greg H Bailey, M.D. | Director | |
| J Milton Harris | Executive Officer, Director | |
| Tacey R Viegas | Executive Officer | |
| Michael D Bentley | Executive Officer, Director |
Other biotechnology companies in Alabama that filed recently
- Khaya Biosciences, Inc. $200,000 · Aug 13, 2026
Every Form D from the week of Mar 27, 2023 · All recent filings in Alabama · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Serina Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.